Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 224

The DOI matches its OpenAlex record; 5 of the 5 references it cites were found in a registry or an index.

Myc confers androgen-independent prostate cancer cell growth

Open access
David Bernard, Albin Pourtier, Jesús Gil, David Beach·2003·Journal of Clinical Investigation

Abstract

Prostate cancer is one of the most diagnosed and mortal cancers in western countries. A major clinical problem is the development of androgen-independent prostate cancer (AIPC) during antihormonal treatment. The molecular mechanisms underlying the change from androgen dependence to independence of these tumors are poorly understood and represent a challenge to develop new therapies. Based on genetic data showing amplification of the c-myc gene in AIPC, we studied the ability of c-myc to confer AIPC cell growth. Human androgen-dependent prostate cancer cells overexpressing c-myc grew independently of androgens and presented tumorigenic properties in androgen-depleted conditions. Analysis of signalling pathways by pharmacological inhibitors of the androgen receptor (AR) or by RNA interference directed against AR or c-myc showed that c-myc acted downstream of AR through multiple growth effectors. Thus c-myc is required for androgen-dependent growth and following ectopic expression can induce androgen-independent growth. Moreover, RNA interference directed against c-myc showed that growth of human AIPC cells, AR-positive or -negative, required c-myc expression. Furthermore, we showed that c-myc-overexpressing cells retain a functional p53 pathway and thus respond to etoposide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1172/jci19035

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 35

  1. Craft, 1999, Nat. Med., 5, 280, 10.1038/6495 · DOI · Paper page
  2. Taplin, 1999, Cancer Res., 59, 2511
  3. Zhao, 2000, Nat. Med., 6, 703, 10.1038/76287 · DOI · Paper page
  4. Edwards, 2001, BJU Int., 88, 633, 10.1046/j.1464-410X.2001.02350.x · DOI
  5. Marcelli, 2000, Cancer Res., 60, 944
  6. Savinainen, 2002, Am. J. Pathol., 160, 339, 10.1016/S0002-9440(10)64377-5 · DOI
  7. Signoretti, 2000, J. Natl. Cancer Inst., 92, 1918, 10.1093/jnci/92.23.1918 · DOI · Paper page
  8. Nupponen, 1998, Am. J. Pathol., 153, 141, 10.1016/S0002-9440(10)65554-X · DOI · Paper page
  9. Visakorpi, 1995, Cancer Res., 55, 342
  10. Kaltz-Wittmer, 2000, Lab. Invest., 80, 1455, 10.1038/labinvest.3780152 · DOI
  11. Nesbit, 1999, Oncogene., 18, 3004, 10.1038/sj.onc.1202746 · DOI · Paper page
  12. Wang, 1998, Genes Dev., 12, 1769, 10.1101/gad.12.12.1769 · DOI · Paper page
  13. Wolf, 1992, Mol. Endocrinol., 6, 753, 10.1210/me.6.5.753 · doi:10.1210/me.6.5.753
  14. Ahlgren, 2000, Prostate., 42, 274, 10.1002/(SICI)1097-0045(20000301)42:4<274::AID-PROS4>3.0.CO;2-R · doi:10.1002/(sici)1097-0045(20000301)42:4<274::aid-pros4>3.0.co;2-r
  15. Ismail, 2002, Prostate., 51, 117, 10.1002/pros.10066 · doi:10.1002/pros.10066
  16. Goodrich, 1992, Nature., 360, 177, 10.1038/360177a0 · DOI
  17. Vlach, 1996, EMBO J., 15, 6595, 10.1002/j.1460-2075.1996.tb01050.x · DOI · Paper page
  18. Carrano, 1999, Nat. Cell Biol., 1, 193, 10.1038/12013 · DOI · Paper page
  19. Hermeking, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 2229, 10.1073/pnas.050586197 · DOI · Paper page
  20. Mateyak, 1999, Mol. Cell. Biol., 19, 4672, 10.1128/MCB.19.7.4672 · DOI · Paper page
  21. Bello-Fernandez, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 7804, 10.1073/pnas.90.16.7804 · DOI · Paper page
  22. Berns, 2000, Oncogene., 19, 3330, 10.1038/sj.onc.1203639 · DOI
  23. Ge, 2000, Int. J. Cancer., 86, 155, 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M · DOI
  24. Eagle, 1995, Nat. Genet., 9, 249, 10.1038/ng0395-249 · DOI · Paper page
  25. Yeh, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 5458, 10.1073/pnas.96.10.5458 · DOI · Paper page
  26. Quarmby, 1987, Mol. Endocrinol., 1, 865, 10.1210/mend-1-12-865 · DOI
  27. Ling, 2001, J. Endocrinol., 170, 287, 10.1677/joe.0.1700287 · DOI
  28. Asadi, 1995, Int. Urol. Nephrol., 27, 67, 10.1007/BF02575223 · doi:10.1007/bf02575223
  29. Silva, 2001, Endocr. Res., 27, 153, 10.1081/ERC-100107177 · DOI
  30. Zhang, 2000, Prostate., 43, 278, 10.1002/1097-0045(20000601)43:4<278::AID-PROS7>3.0.CO;2-4 · doi:10.1002/1097-0045(20000601)43:4<278::aid-pros7>3.0.co;2-4
  31. Brown, 2002, J. Pathol., 198, 237, 10.1002/path.1206 · DOI
  32. Linja, 2001, Cancer Res., 61, 3550
  33. Miyoshi, 2000, Prostate., 43, 225, 10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7 · doi:10.1002/(sici)1097-0045(20000515)43:3<225::aid-pros9>3.0.co;2-7
  34. Sasaki, 2002, J. Natl. Cancer Inst., 94, 384, 10.1093/jnci/94.5.384 · DOI · Paper page
  35. Miyoshi, 2001, BJU Int., 88, 982, 10.1046/j.1464-4096.2001.00936.x · DOI

Cited by

See all 224

Metadata

Authors
Bernard, D., Pourtier, A., Gil, J., & Beach, D.
Venue
Journal of Clinical Investigation
Published
2003-12-01
Volume
112
Issue
11
Pages
1724-1731
ISSN
0021-9738 (ISSN-L)
OpenAlex
W4235592864
Cited by
224
References
5
FWCI
9.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myc confers androgen-independent prostate cancer cell growth. https://app.cochat.ai/papers/10.1172/jci19035
The paper
Bernard, D., Pourtier, A., Gil, J., & Beach, D. (2003). Myc confers androgen-independent prostate cancer cell growth. Journal of Clinical Investigation. https://doi.org/10.1172/jci19035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.